Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia

28 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiovascular prevention outcomes I Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

19 More presentations in this session

Presentation thumbnail
Doctor D. Huber (Umea, SE)
Presentation thumbnail
Doctor T. Sharma (Baltimore, US)
Presentation thumbnail
Doctor C. Badu-Boateng (Reading, GB)
Presentation thumbnail
Ms C. Barboza (Sao Paulo, BR)
Presentation thumbnail
Doctor D. Brie (Timisoara, RO)

The Event

Event poster

ESC Congress 2016

28 August 2016 08:30 CET

ESC 365 is supported by

ESC 365 is supported by